These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Skin Cap and corticosteroids. Boyce D Dermatol Online J; 1997 Dec; 3(2):11e-11f. PubMed ID: 10328674 [No Abstract] [Full Text] [Related]
3. Skin Cap: what have we learned, and when did we learn it? Smith K Dermatol Online J; 1997 Dec; 3(2):11c. PubMed ID: 10217740 [No Abstract] [Full Text] [Related]
4. Immediacy is both a liability and an asset of the Internet. Huntley A Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739 [No Abstract] [Full Text] [Related]
5. Skin Cap analysis in Spain. Sanmartin O Dermatol Online J; 1997 Dec; 3(2):11g. PubMed ID: 10328675 [No Abstract] [Full Text] [Related]
6. Histopathology of psoriasis treated with zinc pyrithione. Aliaga A Am J Dermatopathol; 2001 Apr; 23(2):161-2. PubMed ID: 11285418 [No Abstract] [Full Text] [Related]
7. Pustular psoriasis and hepatotoxicity associated with use of Skin Cap spray. Tan JK Dermatol Online J; 1997 Dec; 3(2):11d. PubMed ID: 10328673 [No Abstract] [Full Text] [Related]
9. The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Crutchfield CE; Lewis EJ; Zelickson BD Dermatol Online J; 1997 Mar; 3(1):3. PubMed ID: 9141364 [TBL] [Abstract][Full Text] [Related]
10. Treatment of localized psoriasis with a topical formulation of zinc pyrithione. Sadeghian G; Ziaei H; Nilforoushzadeh MA Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(4):187-90. PubMed ID: 22367374 [TBL] [Abstract][Full Text] [Related]
11. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013 [TBL] [Abstract][Full Text] [Related]
13. Histopathology of psoriasis treated with zinc pyrithione. Rowlands CG; Danby FW Am J Dermatopathol; 2000 Jun; 22(3):272-6. PubMed ID: 10871074 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. Lorette G; Ermosilla V Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479 [TBL] [Abstract][Full Text] [Related]
15. [Salicylic acid as a keratolytic agent]. Béani JC Ann Dermatol Venereol; 2002; 129(6-7):933-5. PubMed ID: 12218932 [No Abstract] [Full Text] [Related]
16. Coexistence of morphea and psoriasis responding to acitretin treatment. Bilen N; Apaydin R; Erçin C; Harova G; Başdaş F; Bayramgürler D J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):113-7. PubMed ID: 10568490 [TBL] [Abstract][Full Text] [Related]
17. Case of multiple verrucous carcinomas responding to treatment with acetretin more likely to have been a case of verrucous psoriasis. Larsen F; Susa JS; Cockerell CJ; Abramovits W J Am Acad Dermatol; 2007 Sep; 57(3):534-5. PubMed ID: 17707161 [No Abstract] [Full Text] [Related]
18. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study. Saple DG; Ravichandran G; Desai A J Indian Med Assoc; 2000 Dec; 98(12):810-1. PubMed ID: 11394481 [TBL] [Abstract][Full Text] [Related]
19. Emollients, moisturizers, and keratolytic agents in psoriasis. Fluhr JW; Cavallotti C; Berardesca E Clin Dermatol; 2008; 26(4):380-6. PubMed ID: 18691519 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of acitretin in severe psoriasis. Geiger JM Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]